| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3028752 | Thrombosis Research | 2006 | 7 Pages |
Abstract
Our findings are consistent with the observations of increased erythrocyte aggregation, increased erythrocyte/endothelium interaction, and increased plasma ICAM-1 levels observed in sickle cell disease and β-thalassemia patients. This model may be useful for studying therapeutic agents that disrupt erythrocyte/endothelium interactions.
Keywords
LPSthrombin–antithrombin III complexvascular cellular adhesion molecule2-ButoxyethanolVCAM-1ATIIIICAM-1APTTDICantithrombin IIIenzyme linked immunosorbent assayDIC, Disseminated intravascular coagulationSickle cell diseaseTATmicrovascular thrombosisELISAactivated partial thromboplastin timeprothrombin timePhosphatidylserinelipopolysaccharideAnimal modelsintercellular adhesion molecule-1Hemolysis
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Deborah A. Lewis, Abraham Nyska, Anil Potti, Heather A. Hoke, Keith F. Klemp, Sandra M. Ward, Shyamal D. Peddada, Jogin Wu, Thomas L. Ortel,